Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
BAX
BUYBaxter International Inc. · Healthcare · United States · $11.6B · Avg Vol: $138M/d
COMPANY DESCRIPTION
Baxter International Inc. is a global healthcare company providing a broad portfolio of essential healthcare products, including kidney dialysis, sterile IV solutions, infusion systems, and surgical equipment. The company benefits from high switching costs for critical medical devices and a global installed base within hospitals and clinics. Baxter is a significant player in kidney care and hospital products, offering life-sustaining therapies and essential medical technologies worldwide.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.1B | 10.4B | 10.6B | 11.2B | 3.8% | 11.3B | 11.4B | 11.6B | 1.5% |
| EPS | -4.83 | 5.25 | -1.27 | -1.87 | — | -1.86 | — | — | — |
| Shares | 504.4M | 507.6M | 510.9M | 514.3M | +2.0% | 516.5M | — | — | — |
| Debt | 17.2B | 14.1B | 13.4B | 9.8B | -17.2% | 9.7B | — | — | — |
| Equity | 5.8B | 8.4B | 7.0B | 6.1B | 1.7% | — | — | — | — |
| Op CF | 1.2B | 1.7B | 1.0B | 845.0M | -11.3% | 1.3B | — | — | — |
| Inv CF | -931.0M | 3.2B | -626.0M | 2.8B | — | — | — | — | — |
| Fin CF | -1.4B | -3.5B | -1.1B | -4.2B | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of BAX are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| BAX | Baxter International Inc.(you) | $11.6B | 69 | BUY |
| ATR | AptarGroup, Inc. | $8.4B | 74 | BUY |
| SOLV | Solventum Corporation | $13.5B | 78 | BUY |
| TFX | Teleflex Incorporated | $5.8B | 70 | BUY |
| AVTR | Avantor, Inc. | $7.8B | 62 | HOLD |
| COO | The Cooper Companies, Inc. | $13.7B | 54 | HOLD |
| WST | West Pharmaceutical Services, Inc. | $23.1B | 77 | BUY |
| ALGN | Align Technology, Inc. | $12.0B | 93 | STRONG BUY |
| RMD | ResMed Inc. | $28.3B | 78 | BUY |
| MMSI | Merit Medical Systems, Inc. | $4.4B | 78 | BUY |
Peer medians: ROE -25.6% · P/E 27.7x · Gross margin 50.7%